WVU addresses addiction crisis with novel ultrasound treatment

WVU Today

On the heels of the country’s deadliest year for drug overdoses, the West Virginia University Rockefeller Neuroscience Institute launched a first-in-the-world clinical trial to investigate the use of focused ultrasound technology to treat those with opioid use disorder.

Brain surgery may combat opioid addiction.

Good Morning America

Deep brain stimulation, or DBS, via pacemaker technology may help those battling the addiction, which kills 128 Americans every day.

Wearable tech can spot coronavirus symptoms before you even realize you’re sick. Here’s how.

The Washington Post

The RNI is applying its Integrated Neuroscience infrastructure to  rapidly deploy an innovative national study to understand the spread of COVID-19, while protecting our health and economy.

I have no desire to use’: Patient finds brain implant may be the key to beating addiction

 The Washington Post

Gerod Buckhalter, 33, said he had been unable to remain sober for more than four months since the age of 15, despite a variety of treatments . The RNI used deep brain stimulation in hopes of curing Gerod’s cravings for drugs in the first such procedure performed in the United States.

RNI gives patient hope and a steady hand, to hold those he loves the most

CBS Pittsburgh

WVU Medicine is the first and only health system in West Virginia and the region using MR-guided focused ultrasound to treat Essential Tremor and Parkinson’s Disease.

Meet Judi Polak, Alzheimer’s patient and star of a clinical trial showing promising results

PBS NewsHour

The WVU Rockefeller Neuroscience Institute was the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease.

Gold medalist and Marine Corp. among those benefiting from Human Performance Innovation Lab


The RNI’s Human Performance Innovation Center has created a living laboratory that is helping athletes get stronger cognitively, physically, and emotionally, as well as improving recovery with state-of-the-art technology

First in the World Clinical Trial of Non-Opioid Micropellet for Chronic Pain

WVU Today

As part of an ongoing commitment to battle opioid addiction, the WVU Rockefeller Neuroscience Institute marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.

Integrating all components of neurosciences under one roof

WVU School of Medicine News

The RNI established a new department, the Department of Neuroradiology. The department’s mission is to advance knowledge of the nervous system through imaging and to use that knowledge for delivering targeting therapies in the head, neck, and spine.


The Pandemic is Stressing Your Body in New Ways

The New York Times  I  June 4, 2020

W.Va.-Based Study Aims To Predict Coronavirus Exposure Early

WV Public Broadcasting  I  May 13, 2020

Predicting when health care workers could get COVID-19

Pittsburgh Buisness Times I  April 13, 2020


This fund allows the Rockefeller Neuroscience Institute to break barriers in research and patient care.

Your generosity provides momentum for the Rockefeller Neuroscience Institute to leverage cutting-edge technologies and strategic alliances to overcome the barriers to resolving some of the most persistent public health challenges, ranging from addiction to Alzheimer’s disease.